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DOI 10.1186/s12887-014-0302-7RESEARCH ARTICLE Open AccessGeneralized joint hypermobility in childhood is a
possible risk for the development of joint pain in
adolescence: a cohort study
Oline Sohrbeck-Nøhr1, Jens Halkjær Kristensen2, Eleanor Boyle1,3, Lars Remvig2 and Birgit Juul-Kristensen1,4*Abstract
Background: There is some evidence that indicates generalized joint hypermobility (GJH) is a risk factor for pain
persistence and recurrence in adolescence. However, how early pain develops and whether GJH without pain in
childhood is a risk factor for pain development in adolescence is undetermined. The aims for this study were to
investigate the association between GJH and development of joint pain and to investigate the current GJH status
and physical function in Danish adolescents.
Methods: This was a longitudinal cohort study nested within the Copenhagen Hypermobility Cohort. All children
(n = 301) were examined for the exposure, GJH, using the Beighton test at baseline at either 8 or 10 years of age
and then re-examined when they reached 14 years of age. The children were categorized into two groups based
on their number of positive Beighton tests using different cut points (i.e. GJH4 defined as either < 4 or ≥ 4, GJH5
and GJH6 were similarly defined). The outcome of joint pain was defined as arthralgia as measured by the Brighton
criteria from the clinical examination. Other outcome measures of self-reported physical function and objective
physical function were also collected.
Results: Children with GJH had three times higher risk of developing joint pain in adolescence, although this
association did not reach statistical significance (GJH5: 3.00, 95% [0.94-9.60]). At age 14, the adolescents with GJH
had significantly lower self-reported physical function (for ADL: GJH4 p = 0.002, GJH5 p = 0.012; for pain during
sitting: GJH4 p = 0.002, GJH5 p = 0.018) and had significantly higher body mass index (BMI: GJH5 p = 0.004, GJH6
p = 0.006) than adolescents without GJH. There was no difference in measured physical function.
Conclusion: This study has suggested a possible link between GJH and joint pain in the adolescent population.
GJH was both a predictive and a contributing factor for future pain. Additional studies with larger sample sizes are
needed to confirm our findings.
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Musculoskeletal disorders are often characterized by
pain and physical impairment. This may influence the
quality-of-life of an individual, which could cause an
economic burden to the society [1,2]. Generalized joint
hypermobility (GJH) is one of the musculoskeletal disor-
ders, and is defined by a certain number of positive joint* Correspondence: bjuul-kristensen@health.sdu.dk
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article, unless otherwise stated.mobility tests [3]. Further, GJH is part of the diagnostic
criteria for benign joint hypermobility syndrome (BJHS)
[4]. Prevalence of GJH varies according to age, sex and
ethnicity. It also varies based on the diagnostic criteria
used and the reliability of the joint mobility test [5].
Generally, a threshold of four or more positive joints out
of 9 possible using the Beighton tests (GJH4) is used to
determine GJH for adults [3]. However, to date there are
no consensus criteria for GJH in children. Since joint
laxity decreases with age [5], a higher number of positive
Beighton tests has been suggested as a diagnostic criteria
for children, (i.e. ≥6 positive Beighton tests (GJH6) forCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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has been estimated to be between 29% to 35%, whereas
the prevalence of GJH6 has been reported to be between
9% to 11% [7,8].
The relationship between musculoskeletal complaints
and GJH has been investigated in a few studies, but the
studies either indicated a relationship [9-11] or were un-
able to confirm this [12,13]. GJH has been hypothesized
to be a risk factor for developing musculoskeletal pain,
but it is unknown how early this pain develops. Children
at 10 years with GJH and musculoskeletal pain have in-
creased risk of pain persistence and pain recurrence in
adolescence [9,10], but whether GJH without pain in
childhood is a risk factor for pain development in adoles-
cence is unclear. There is a need to increase the know-
ledge about when pain develops, in whom it develops, and
how it may impact on physical functioning for adoles-
cents. This information will be useful for developing pre-
ventive strategies for children with GJH [14,15].
The connection between GJH and physical functioning
has been investigated. Some studies have shown an asso-
ciation between GJH with neuromuscular and motor de-
velopment dysfunction [16-18] as explained by a poor
proprioception [19,20]. Other studies have found con-
flicting evidence where children with GJH had a higher
vertical jump height, had better static balance, had faster
speed skills, and faster reaction skills than children with-
out GJH [7,8].
The current study had two aims. The first was to in-
vestigate the association between GJH and development
of joint pain in adolescents. The second was to investi-
gate the current GJH status and self-reported physical
functioning and objectively measured physical function
by re-examination, respectively, six and four years after
the enrolment.
Methods
This study was a cohort study [21,22] within the Copenhagen
Hypermobility Cohort (COHYPCO).
Procedures
This study was a continuation of two cross-sectional sur-
veys of a representative sample of preadolescent Danish
school children. The surveys took place at two different
municipalities in the rural area of Greater Copenhagen,
Denmark: 1) the Ballerup and 2) Taarnby municipalities.
The children in the Ballerup cohort were examined at
eight years of age in 2006, and the children in the Taarnby
cohort were examined at ten years of age in 2008. The two
cohorts together formed the COHYPCO [7,8].
In 2012, the children and their parents were re-invited
to participate in the COHYPCO study by an information
letter sent through the online school communication
system. Parents, children and their teachers were invitedto an information meeting that was held in the two mu-
nicipalities. The children were examined at school from
November to December 2012. Children who were on sick-
leave or on vacation were either examined in January 2013
or in April-May 2013.
The Regional Committees on Health Research Ethics
for Southern Denmark did not consider this study to be
invasive and therefore, no ethics approval was war-
ranted. Parents of each participating child gave their in-
formed consent according to the Declaration of Helsinki
[23], and before examination each child gave oral assent
to participate.
Study population
Participants for this study were selected according to
their GJH status and pain status at baseline. All children
of Caucasian origin, with no pain at baseline, and cate-
gorized as ≥GJH4 (n = 222) at baseline were defined as
cases (Figure 1). Age- and sex-matched controls were
randomly chosen on a ratio of 1:1 from Caucasian
children (within the same class) who were categorized
as < GJH4 (n = 222) at baseline. At follow-up, all par-
ticipants were in the eighth grade, except for one who
was in the seventh grade. Fifteen different public schools
in the two municipalities participated.
Measurements
Clinical examination
The clinical and motor competence examination took
place at each school during school-time. The children
were not allowed any stretching or warm-up before test-
ing. They were tested in groups of three to four. The
duration of examination varied from 45 to 60 minutes
for each group and was performed by four examiners.
One examiner (one of the two medical doctors (MD’s))
was responsible for the clinical examination and two of
the motor competence tests (i.e. dynamic balance and
muscle explosive force), one examiner (physiotherapist
(PT)) was responsible for the third motor competence
test (i.e. static balance), one examiner was responsible
for administering the questionnaire (PT), and the last
examiner was responsible for the logistics and communi-
cation between players. All examiners, who were trained
thoroughly in carrying out the test battery, were mutu-
ally blinded to each other’s results and to the baseline
GJH status. The same clinical examination tests and cri-
teria used in the baseline, previously shown to have high
inter-examiner reproducibility for diagnosing GJH and
BJHS, kappa values of 0.74 and 0.84 [24], were used in
the follow-up.
Motor competence
The three motor competence tests focused on motor
competence in the lower extremities (i.e. static balance,
Figure 1 Flowchart of children included in the study.
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dren were allowed to practice the actual motor compe-
tence tests for three times before being tested.
Static balance comprised of testing postural sway in
three different standing balance tasks on a Wii Balance
Board (WBB) (Nintendo, Kyoto, Japan) [25]. These bal-
ance tests were as follows: Romberg test with eyes open,
Romberg test with eyes closed, and one-leg stance (on
dominant leg) with eyes open [26]. The children stood
with bare feet on the balance board, arms crossed over
their chest, and were instructed to remain as still as
possible for the whole trial of 30 seconds. Sampling
frequency was 20 Hz. Romberg open eyes test was mea-
sured one time for familiarization and the two remaining
balance tests were repeated three times. The averages for
these were used to calculate the following parameters:
95% confidence ellipse area of the centre of pressure (incm2), anterior-posterior displacement (in cm), medial-
lateral range displacement (in cm) and centre of pressure
path length (in mm). These tests have been found to have
satisfactory reproducibility for a children aged 10–14 [27].
Dynamic balance was measured using the zig-zag
jumping test from Movement ABC-2 [28], which re-
cently has been found to be a valid instrument for meas-
uring activities in children [29]. The children performed
barefoot one-legged jumping on six mats positioned in a
zig-zag row. The number of correct consecutive jumps
from the start (maximum 5) without resting was noted.
The children had one practice attempt with each leg. If
the maximum number of jumps was achieved in the first
attempt, there were no more additional attempts; other-
wise, the test was performed a maximum of twice per
leg (scoring 0–6). The maximum score of six was only
achieved for 5 consecutive jumps in the first trial. The
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formed. The best score for each leg was selected.
Muscle explosive force was measured using the child’s
height and vertical jump on two legs (i.e. Abalakov’s
test). This is a widely used test to investigate explosive
strength or power, but to our knowledge reliability or
validity has not been documented in children or adoles-
cents [30]. The highest jump out of three attempts was
selected [8].
Questionnaire
On the day of the examination, the Rheumatoid and
Arthritis Outcome Score for children (RAOS-child
version 1) questionnaire was filled out electronically by
each child. This questionnaire was developed for chil-
dren and it is in the same format as the Knee Osteoarth-
ritis Outcome Score for children (KOOS-child). The
KOOS-child has been validated in children aged 10–12
years, but only covers the knee [31]. The RAOS-child
questionnaire consists of questions about physical func-
tioning for three body parts: the knee, hip and ankle.
Similar modifications have been done to the KOOS
questionnaire for adults [32], called RAOS [33] which
has been found to be a valid, reliable and responsive out-
come measurement. These properties have not been
tested for the RAOS-child, but it is assumed that the
questionnaire has similar properties as the adult version.
RAOS-child contains five domains: symptoms, pain, ac-
tivities of daily living (ADL), sport and quality-of-life
(QOL). There are 46 questions. Each question has 5 re-
sponse categories, scored from 0 to 4 (0 = none, 1 = mild,
2 =moderate, 3 = severe, 4 = extreme). The total score
for each dimension is calculated as follows [31]:
100 minus average of that dimensionð Þ=4
 100; meaning 100 is equal to normal function
Additional questions on musculoskeletal health in rela-
tion to prior injuries (‘Have you experienced dislocation or
subluxation in one joint?’ yes/no; ‘Have you experienced
epicondylitis, tenosynovitis or bursitis?’ yes/no), physical
activity (‘Do you do any sports in your spare time?’ yes/no;
’At what level are you practising your primary sports activ-
ity?’ Elite/sub elite/exercise level; ‘How many hours a week
are you practicing your primary sports activity?’). Sub-
jective pain disabilities (SPD) were also included in the
questionnaire. These questions have shown to have high
reliability in a population of school children in third and
fifth grade (kappa = 0.9) [6].
Measurements for exposure, outcome and confounders
Beighton scores at baseline and follow-up were used as
independent variables for the exposure GJH. Data was
reported using three different definitions based on thenumber of positive Beighton tests. Definition 1: <GJH4
versus (vs) ≥GJH4 (Beighton score of 4) [3], definition 2:
<GJH5 vs. ≥GJH5 (Beighton score of 5) [6], and defin-
ition 3: <GJH6 vs. ≥GJH6 (Beighton score of 6) [7,8].
The Brighton criterion regarding arthralgia (i.e. pain in
more than four joints for more than three months) mea-
sured at follow-up was used as dependent factor for joint
pain.
For the association between GJH at baseline and joint
pain at follow-up, age and sex at baseline were tested as
potential confounders. For the association between cur-
rent GJH status and joint pain, the following variables at
follow-up were tested as potential confounders: age, sex,
BMI (body mass index), previous lower limb injuries,
physical activity and motor competence.
Data analysis and statistics
Descriptive statistics were summarized using either fre-
quency tables or means/medians. Data was reported by
the three classifications with respect to the number of
positive Beighton tests. Group differences in demog-
raphy, self-reported (RAOS-child, SPD) and measured
physical function (motor competence tests) were tested
using independent t-test for the parametric data and ei-
ther Mann–Whitney U-test, chi-square test or Fisher’s
exact test for the non-parametric data. P-values less than
0.05 (two-tailed) were considered statistically significant.
An unadjusted logistic regression model was com-
puted to determine whether GJH was a predictive and/
or an associative factor for reporting joint pain. Potential
baseline or follow-up confounders were individually
added to the unadjusted model. If the β-coefficient of
GJH changed by more than 10% this variable was consid-
ered a confounder and was included in the final multivari-
able logistic regression model [34]. Statistical significance
required that the 95% Confidence Interval (CI) did not in-
clude 1. All analyses were performed in SPSS version 21
(IBM SPSS Inc, Chicago, IL, USA).
Results
Participants
In total, 301 (82% of invitees) children of Caucasian ori-
gin (median age 14.00 [range = 13–15]) completed the
follow-up examination. Reasons for non-participation in-
cluded: missing consent from parents, declining partici-
pation, absence from school on examination day, having
moved school/region after inclusion and other reasons
(such as other chronic diseases) (Figure 1). The demog-
raphy for the three definitions of GJH is presented in
Table 1. There was significantly higher proportion of
girls than boys with GJH4 (p = 0.035) and GJH6 (p =
0.034), and GJH5 and GJH6 had statistically higher BMI
than their respective control groups (GJH5: p = 0.004,
GJH6: p = 0.006).
Table 1 Demography by the three definitions of generalized joint hypermobility (GJH)
GJH4 GJH5 GJH6
Variable < GJH4 ≥ GJH4 p-value < GJH5 ≥ GJH5 p-value < GJH6 ≥ GJH6 p-value
(n = 171) (n = 130) (n = 217) (n = 84) (n = 237) (n = 64)
Age, median (range) 14 (13–15) 14 (13–15) 0.13 14 (13–15) 14 (13–15) 0.24 14 (13–15) 14 (13–15) 0.61
1BMI, mean (sd) 20.02 (2.62) 20.57 (2.77) 0.08 19.95 (2.52) 21.03 (2.98) 0.004* 20.03 (2.62) 21.07 (2.85) 0.006*
Gender, no. of girls, n (%) 75 (43.9) 73 (56.2) 0.04a,* 100 (46.1) 48 (57.1) 0.09a 109 (46.0) 39 (60.9) 0.03a,*
Musculoskeletal health, n (%)
Arthralgia in 1–3 joints
(> 3 months), (n = 301)
9 (5.3) 10 (7.7) 0.39a 12 (5.5) 7 (8.3) 0.37a 14 (5.9) 5 (7.8) 0.58a
Arthralgia in >4 joints
(> 3 months), (n = 300)
4 (2.3) 8 (6.2) 0.14b 6 (2.8) 6 (7.1) 0.08a 7 (3.0) 5 (7.8) 0.08a
2Dislocation/subluxation, (n = 293) 10 (5.8) 9 (6.9) 0.70a 11 (5.1) 8 (9.5) 0.15a 13 (5.5) 6 (9.4) 0.26a
3Soft tissue rheumatism, (n = 293) 5 (2.9) 5 (3.8) 0.66a 6 (2.8) 4 (4.8) 0.47b 8 (3.4) 2 (3.1) 1.00b
1BMI = Body Mass Index (calculated as = bodyweight in kg/ height in m*height in m) 2Dislocation/subluxation is based on the question: ‘Have you experienced
dislocation or subluxation in one joint’. 3Soft tissue rheumatism is based on the question: ‘Have you experienced epicondylitis, tenosynovitis or bursitis?’
Methods/Hypothesis testing: Age: Mann Whitney u-test; BMI (body mass index): independent t-test; Gender, musculoskeletal health: X2, aPearson’s chi-square;
bFishers exact test. Significant difference between groups are marked with *and written with bold.
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In the longitudinal analysis, children with GJH based on
the GJH5 definition at baseline had a threefold increased
risk for developing joint pain at follow-up, although this
association did not reach statistical significance (GJH5;
3.00 [0.94-9.60]) (Table 2). There were no identified con-
founders for the associations for GJH5 and GJH6 and
therefore, it was not possible to conduct an adjusted
model.
In the unadjusted logistic regression analysis, children
with GJH (independent of cut-off level) had three times
higher risk of reporting joint pain at follow-up, althoughTable 2 Longitudinal data: Odds ratio (OR) for generalized










OR (95% CI) OR (95% CI)
Exposure
<GJH41 5 145 1.00 1.00
≥GJH41 7 143 1.42 (0.44–4.58) 1.37 (0.42–4.43)c
<GJH52 6 216 1.00
≥GJH52 6 72 3.00 (0.94–9.60) NCd
<GJH63 9 241 1.00
≥GJH63 3 47 1.71 (0.45–6.55) NCd
1< GJH4 versus ≥ GJH4 = 3 versus 4 or more positive Beighton tests out of a
maximum of 9 Beighton tests 2< GJH5 versus ≥ GJH5 = 4 versus 5 or more
positive Beighton tests out of a maximum of 9 Beighton tests 3< GJH6
versus ≥ GJH6 = 5 versus 6 or more positive Beighton tests out of a maximum
of 9 Beighton tests.
aOutcome (arthralgia) measured at follow-up at 14 years old, exposure (GJH)
measured at baseline at eight or ten years old (cohort study). bUnivariate model.
cMultivariable model adjusted to gender. dNo confounders identified for this
association and no multivariable models conducted. NC = not conducted.this association did not reach statistical significance (OR
[95% CI]; GJH4: 2.76 [0.81-9.38], GJH5: 2.96 [0.84-8.60],
GJH6: 2.77 [0.85-9.05]) (Table 3). Controlling for poten-
tial confounders did not change these results.Self-reported and measured physical function at follow-up
Self-reported ADL as reported in the RAOS-child ques-
tionnaire was significantly lower (poorer) in the children
with GJH (i.e. GJH4 (p = 0.002) and GJH5 (p = 0.012))
(Table 4). For the SPD, there was significantly higherTable 3 Odds ratio (OR) for generalized joint










OR (95% CI) OR (95% CI)
Exposure
<GJH41 4 167 1.00 1.00
≥GJH41 8 121 2.76 (0.81–9.38) 2.16 (0.61–7.64)c
<GJH52 6 210 1.00 1.00
≥GJH52 6 78 2.69 (0.84–8.60) 2.38 (0.66–8.60)d
<GJH63 7 229 1.00 1.00
≥GJH63 5 59 2.77 (0.85–9.05) 2.36 (0.61–9.10)e
1< GJH4 versus ≥ GJH4 = 3 versus 4 or more positive Beighton tests out of a
maximum of 9 Beighton tests 2< GJH5 versus ≥ GJH5 = 4 versus 5 or more
positive Beighton tests out of a maximum of 9 Beighton tests 3< GJH6
versus ≥ GJH6 = 5 versus 6 or more positive Beighton tests out of a maximum
of 9 Beighton tests.
aOutcome (arthralgia) and exposure (GJH) measured at follow-up at 14 years
old (cross-sectional). bUnivariate model. cMultivariable model adjusted to
gender, sway. dMultivariable model adjusted to gender, previous lower limb
injuries (yes/no), sway. eMultivariable model adjusted to gender, previous
lower limb injuries (yes/no), vertical jump, sway.
Table 4 Self-reported physical function and physical activity for the three definitions of generalized joint hypermobility
(GJH) for children at the age of 14
GJH4 GJH5 GJH6
Variable < GJH4 ≥ GJH4 p-value < GJH5 ≥ GJH5 p-value < GJH6 ≥ GJH6 p-value
(n = 171) (n = 130) (n = 217) (n = 84) (n = 237) (n = 64)
1RAOS-child , mean (sd)
Symptoms (n = 299) 88.55 (11.04) 86.10 (12.51) 0.16 87.82 (11.80) 86.67 (11.60) 0.39 87.73 (11.90) 86.68 (11.15) 0.34
Pain (n = 293) 89.53 (10.08) 87.01 (10.81) 0.02* 88.97 (10.31) 87.09 (10.80) 0.10 88.77 (10.56) 87.24 (10.07) 0.12
ADL (n = 293) 96.00 (6.22) 94.47 (5.84) 0.002* 95.70 (6.17) 94.44 (5.84) 0.012* 95.54 (6.20) 94.64 (5.67) 0.06
Sport (n = 296) 87.59 (14.08) 84.31 (16.57) 0.07 86.62 (14.91) 85.09 (16.14) 0.42 86.37 (15.17) 85.60 (15.61) 0.56
QOL (n = 297) 82.57 (14.45) 78.52 (17.47) 0.06 81.36 (15.66) 79.42 (16.61) 0.30 81.00 (16.10) 80.16 (15.37) 0.43
Subjective Pain Disabilities
(SPD), n (%)
Pain disturbing sleeping (n = 299) 10 (5.8) 9 (7.0) 0.68 15 (6.9) 4 (4.9) 0.52 15 (6.4) 4 (6.3) 1.00
Pain disturbing sitting during class
(n = 298)
11 (6.4) 23 (18.1) 0.002* 19 (8.8) 15 (18.5) 0.018* 24 (10.2) 10 (16.1) 0.19
Paint disturbing walking > 1 km
(n = 297)
26 (15.2) 25 (19.8) 0.30 36 (16.6) 15 (18.8) 0.66 40 (16.9) 11 (18.0) 0.84
Pain disturbing physical exercise
class (n = 299)
35 (20.5) 36 (28.1) 0.12 49 (22.6) 22 (26.8) 0.44 56 (23.7) 15 (23.8) 0.99
Pain disturbs hobbies (n = 299) 27 (15.8) 28 (21.9) 0.18 38 (17.5) 17 (20.7) 0.52 42 (17.8) 13 (20.6) 0.61
Physical activity
2Sports active, leisure time,
(n = 298), n (%)
137 (80.6) 105 (82.0) 0.75 173 (80.1) 69 (84.1) 0.42 190 (80.9) 52 (82.5) 0.76
3Activity level (n = 245), n (%) 0.88 0.25 0.13
Elite 32 (22.9) 22 (21.0) 40 (22.7) 14 (20.3) 44 (22.8) 10 (19.2)
Sub elite 44 (31.4) 36 (34.3) 52 (29.5) 28 (40.6) 57 (29.5) 23 (44.2)
Exercise level 64 (45.7) 47 (44.8) 84 (47.7) 27 (39.1) 92 (47.7) 19 (36.5)
4Hours per week (n = 299),
median (range)
3.00 (0–23) 3.75 (0–27) 0.70 3.00 (0–23) 4.00 (0–27) 0.25 3.00 (0–23) 4.00 (0–27) 0.12
1RAOS score, with 100 indicating no problems and 0 indicating severe problems. 2Sports active is based on the question: ‘Do you do any sports in you spare
time?’ Rated as yes/no. 3Activity level is based on the question: ‘At what level are you practising you primary sports activity?’ With the answering categories: Sub
elite, elite or exercise level. 4Hours per week is based on the question: ‘How many hours a week are you practicing your primary sports activity?’ Measured as the
group average.
Methods/Hypothesis testing: RAOS, Physical activity (hours per week): Mann–Whitney u-test; SPD, Physical activity: X2 (Pearson’s). Significant difference between
groups are marked with *and written with bold.
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while sitting in class for GJH4 (p = 0.002) and GJH5
(p = 0.018).
Children with GJH did not perform better in motor
competence, neither in static (sway) nor dynamic bal-
ance (zig-zag jump), than children without GJH (Table 5).
Children with GJH had a lower vertical jump height;
however, the difference was not statistically significant
(GJH4 p = 0.33, GJH5 p = 0.15, GJH6 p = 0.12).
Discussion
The result of this study suggested that GJH5 without
pain in childhood at eight or ten years of age is a pos-
sible predictive factor for developing joint pain in adoles-
cence, although this association did not reach the
predefined level of statistical significance. It also indicatedthat there was a positive association between GJH and ex-
periencing joint pain at 14 years of age. Furthermore, we
found that adolescents aged 14 years with GJH5 or GJH6
had significantly higher BMI and self-reported lower phys-
ical functioning. They also experienced daily pain more
frequently.
The association between GJH in childhood and devel-
opment of joint pain in adolescence is partly in accord-
ance with findings from previous studies. Other studies
have found that hypermobility was a significant pre-
dictor for pain recurrence and for pain persistence at the
age of 14 and/or 16 at follow-up [10,35], but was not a
predictor for pain incidence one year later [36]. More
clearly, the current study proposes that GJH is a pre-
dictor (close to reaching significance) for incident joint
pain at six and four years follow-up, indicating an
Table 5 Measured motor competence for the three definitions of generalized joint hypermobility (GJH) at follow-up
GJH4 GJH5 GJH6
Motor competence < GJH4 ≥ GJH4 p-value < GJH5 ≥ GJH5 p-value < GJH6 ≥ GJH6 p-value
(n = 171) (n = 130) (n = 217) (n = 84) (n = 237) (n = 64)
1Zigzag hop, no. of
consecutive hops, median
(range)
Right leg (n = 300) 6 (0–6) 6 (2–6) 0.72 6 (0–6) 6 (3–6) 0.07 6 (0–6) 6 (3–6) 0.018*
Left leg (n = 298) 6 (0–6) 6 (2–6) 0.67 6 (0–6) 116 (2–6) 0.77 6 (0–6) 6 (2–6) 0.74
Vertical jump, cm,
(n = 299), mean (sd)




295% areal, cm2 4.57 (2.26) 5.11 (2.42) 0.05 4.72 (2.24) 5.01 (2.61) 0.72 4.73 (2.26) 5.10 (2.62) 0.45
3Anterior-posterior range, cm 2.53 (0.73) 2.67 (0.84) 0.24 2.56 (0.75) 2.67 (0.85) 0.39 2.57 (0.75) 2.68 (0.90) 0.51
4Medial-lateral range, cm 2.56 (0.67) 2.66 (0.75) 0.48 2.61 (0.70) 2.57 (0.72) 0.34 2.61 (0.70) 2.58 (0.73) 0.54
5Centre of pressure path
length, mm
56.13 (11.74) 56.53 (9.23) 0.46 56.10 (11.15) 56.83 (9.53) 0.39 56.24 (10.99) 56.54 (9.68) 0.74
Romberg closed eyes
(n = 300)
295% areal, cm2 8.83 (3.94) 9.39 (5.43) 0.56 8.85 (3.78) 9.63 (6.35) 0.82 9.08 (4.74) 9.02 (4.26) 0.87
3Anterior-posterior range, cm 3.62 (0.86) 3.67 (1.13) 0.88 3.61 (0.85) 3.72 (1.26) 0.94 3.66 (1.03) 3.57 (0.83) 0.53
4Medial-lateral range, cm 3.78 (0.92) 3.92 (0.90) 0.20 3.82 (0.90) 3.90 (0.95) 0.61 3.85 (0.95) 3.82 (0.77) 0.85
5Centre of pressure path
length, mm
85.55 (24.25) 85.17 (18.69) 0.59 84.95 (22.73) 86.52 (20.04) 0.30 85.64 (23.34) 84.40 (16.07) 0.79
One leg stance (n = 298)
295% areal, cm2 9.80 (3.19) 10.13 (3.73) 0.80 9.90 (3.19) 10.04 (4.02) 0.61 10.01 (3.37) 9.67 (3.69) 0.18
3Anterior-posterior range, cm 4.54 (1.09) 4.63 (1.19) 0.73 4.58 (1.13) 4.57 (1.15) 0.88 4.61 (1.15) 4.44 (1.05) 0.17
4Medial-lateral range, cm 3.25 (0.56) 3.27 (0.61) 0.57 3.27 (0.55) 3.24 (0.65) 0.18 3.27 (0.57) 3.23 (0.63) 0.11
5Centre of pressure path
length, mm
132.26 (37.19) 129.23 (32.72) 0.54 132.72 (37.28) 126.27 (29.19) 0.33 132.68 (37.02) 124.34 (27.11) 0.15
1Zigzag hop measured on a scale from 0–6, where 6: 5 consecutive jumps in first trial; 5: 5 consecutive jumps in second trial; 4: maximum of 4 consecutive jumps;
3: maximum of 3 consecutive jumps; 2: maximum of 2 consecutive jumps; 1: maximum of 1 consecutive jumps; 0: maximum of 0 consecutive jumps. 295% confidence
ellipse area of the Centre of Pressure (cm2) 3Anterior-posterior displacement (cm) 4Medial-lateral range displacement (cm) 5Centre of pressure path length (mm).
Methods/Hypothesis testing: Mann–Whitney U-test. Significant difference between groups are marked with *and written with bold.
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have been no other studies that has reported this. Al-
though a recent study found an increased risk of pain at
18 years of age in children who had GJH at 14 years of
age. Unfortunately, pain status in GJH at baseline was
not reported [11].
We also found that GJH seemed to be a contributing
factor for having joint pain at 14 years of age. This asso-
ciation was not apparent in the baseline cross-sectional
studies of our population when they were aged either
eight or ten, where no relation between GJH and muscu-
loskeletal pain was found. This has been reported in
other studies of children in that age range [6-8]. This
means that an association at early age is possibly not
present. Our current results suggest that the impact ofGJH starts later, somewhere between ages 10 and 14, or at
least at 14 years of age with such relationship approaching
significance in the current longitudinal analysis.
At baseline, there was an equal distribution of children
being < GJH4 vs. ≥GJH4 and between boys and girls.
The number of children with ≥GJH4 from baseline to
follow-up had decreased, supporting that joint laxity is
decreasing by increasing age [5].
In the current cross-sectional study, adolescents with
GJH also reported a lower self-reported physical func-
tion. In a previous study, the self-reported SPD was not
associated with GJH [6], but a higher SPD score was as-
sociated with musculoskeletal pain or pain persistence/
recurrence in children [9,37]. Since GJH in the current
study was associated with pain, it could be likely that
Sohrbeck-Nøhr et al. BMC Pediatrics  (2014) 14:302 Page 8 of 9children with GJH reported lower self-reported physical
functioning due to pain.
At baseline, children with GJH had better motor com-
petence than their classmates (i.e. jump, precision tasks)
[7,8]. However, at follow-up, GJH did not perform better
which may indicate that GJH during the follow-up
period may have influenced motor competence nega-
tively or that the tests were not precise/challenging
enough to differ between the groups.
The estimates for GJH as a contributing factor for hav-
ing joint pain were the same for the three different defi-
nitions. This may indicate that the different cut-off levels
for the number of positive joints had no influence on
the data.
The estimates for both the cross-sectional as well as
for the longitudinal analyses have wide confidence inter-
vals. This affects the statistical power of the results nega-
tively and weakens the association between GJH and
developing joint pain. The small sample size and low
number of outcome events must be an explanation for
this and why these associations should be confirmed in a
larger study. Further to this, the small sample size may
explain the inconsistent pattern of the longitudinal ana-
lysis where GJH5 had the highest OR followed by GJH6
and GJH4.
Including age groups of both eight and ten years at
baseline could be a limiting factor due to the shorter
follow-up period for one of the groups. Therefore, this
could have weakened the association of having GJH as a
child and developing joint pain in adolescence. However,
this was not confirmed, since there was an increased risk
in children at ten compared with eight years at baseline.
Due to the relatively small groups they were pooled into
one large group at follow-up. Taken together, despite the
small number of baseline measurements and outcome
events, we saw an increased risk of pain development in
GJH, suggesting an association between GJH and joint
pain for adolescents who had no pain at baseline.
Selection of a limited number of control subjects was
based on a desire to achieve an equal number of expos-
ure contrasts, knowing that it could have caused system-
atic selection bias. However, since selection criteria were
based on exposure (GJH) and not outcome status (joint
pain), this is unlikely to have biased this association [21].
Measurement of outcome status (conducted by med-
ical history) from the clinical examination was more
likely to be confounded by recall bias than the exposure
status. But since the current outcome (pain in more than
4 joints for more than 3 months) is a relatively “hard”
outcome, it is not likely to have biased this association.
Another weakness of this study was the lack of a full
baseline dataset on potential confounders. Although we
did investigate and adjust for potential confounders, there
may have been residual confounding not accounted forbecause we had no information about the following: injur-
ies at baseline, family history of rheumatic diseases or so-
cioeconomic status.
The strengths of this study were having clinical exami-
nations performed at both baseline and follow-up. This
strengthens the validity of the exposure and outcome,
since the exposure is measured objectively and is there-
fore free of recall bias, and the outcome is a relatively
hard end-point. The examiners performing the clinical
tests were the same as in the baseline studies. Each
examiner tested a random number of children at base-
line and at follow-up, meaning that they did not test the
same child at both test rounds. It is therefore assumed
that the examiners were blinded to the health status of
the child. The examiner blindness also minimizes non-
differential misclassification of both the exposure and
outcome status.
Conclusion
This study suggests a possible link between GJH in child-
hood and joint pain in adolescence. Children at eight or
ten years of age with GJH5 and no pain at baseline were
found to have a threefold increased risk of developing pain
at 14 years of age. Although this association did not reach
the predefined level of statistical significance future studies
with a bigger sample size are needed to confirm these
findings.
Furthermore, adolescents at 14 years of age with GJH
have higher BMI, lower self-reported physical function
and experience daily pain more frequently, but GJH does
not seem to influence measured physical function at
14 years of age.
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